Association of variants in the sterol regulatory element-binding factor 1 (SREBF1) gene with type 2 diabetes, glycemia, and insulin resistance: a study of 15,734 Danish subjects

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Association of variants in the sterol regulatory element-binding factor 1 (SREBF1) gene with type 2 diabetes, glycemia, and insulin resistance: a study of 15,734 Danish subjects. / Grarup, Niels; Stender-Petersen, Kirstine L; Andersson, Ehm A; Jørgensen, Torben; Borch-Johnsen, Knut; Sandbæk, Annelli; Lauritzen, Torsten; Schmitz, Ole; Hansen, Torben; Pedersen, Oluf.

In: Diabetes, Vol. 57, No. 4, 2008, p. 1136-42.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Grarup, N, Stender-Petersen, KL, Andersson, EA, Jørgensen, T, Borch-Johnsen, K, Sandbæk, A, Lauritzen, T, Schmitz, O, Hansen, T & Pedersen, O 2008, 'Association of variants in the sterol regulatory element-binding factor 1 (SREBF1) gene with type 2 diabetes, glycemia, and insulin resistance: a study of 15,734 Danish subjects', Diabetes, vol. 57, no. 4, pp. 1136-42. https://doi.org/10.2337/db07-1534

APA

Grarup, N., Stender-Petersen, K. L., Andersson, E. A., Jørgensen, T., Borch-Johnsen, K., Sandbæk, A., Lauritzen, T., Schmitz, O., Hansen, T., & Pedersen, O. (2008). Association of variants in the sterol regulatory element-binding factor 1 (SREBF1) gene with type 2 diabetes, glycemia, and insulin resistance: a study of 15,734 Danish subjects. Diabetes, 57(4), 1136-42. https://doi.org/10.2337/db07-1534

Vancouver

Grarup N, Stender-Petersen KL, Andersson EA, Jørgensen T, Borch-Johnsen K, Sandbæk A et al. Association of variants in the sterol regulatory element-binding factor 1 (SREBF1) gene with type 2 diabetes, glycemia, and insulin resistance: a study of 15,734 Danish subjects. Diabetes. 2008;57(4):1136-42. https://doi.org/10.2337/db07-1534

Author

Grarup, Niels ; Stender-Petersen, Kirstine L ; Andersson, Ehm A ; Jørgensen, Torben ; Borch-Johnsen, Knut ; Sandbæk, Annelli ; Lauritzen, Torsten ; Schmitz, Ole ; Hansen, Torben ; Pedersen, Oluf. / Association of variants in the sterol regulatory element-binding factor 1 (SREBF1) gene with type 2 diabetes, glycemia, and insulin resistance: a study of 15,734 Danish subjects. In: Diabetes. 2008 ; Vol. 57, No. 4. pp. 1136-42.

Bibtex

@article{58bdbf10ee1f11ddbf70000ea68e967b,
title = "Association of variants in the sterol regulatory element-binding factor 1 (SREBF1) gene with type 2 diabetes, glycemia, and insulin resistance: a study of 15,734 Danish subjects",
abstract = "OBJECTIVE: We evaluated the association of variants in the sterol regulatory element-binding factor 1 gene (SREBF1) with type 2 diabetes. Due to the previous inconclusive quantitative trait associations, we also did studies of intermediate quantitative phenotypes. RESEARCH DESIGN AND METHODS: We genotyped four variants in SREBF1 in the population-based Inter99 cohort (n = 6,070), the Danish ADDITION study (n = 8,662), and in additional type 2 diabetic patients (n = 1,002). The case-control studies involved 2,980 type 2 diabetic patients and 4,522 glucose-tolerant subjects. RESULTS: The minor alleles of rs2297508, rs11868035, and rs1889018 (linkage disequilibrium R(2) = 0.6-0.8) associated with a modestly increased risk of type 2 diabetes (rs2297508: OR 1.17 [95% CI 1.05-1.30], P = 0.003), which was confirmed in meta-analyses of all published studies (rs2297508 G-allele: 1.08 [1.03-1.14] per allele, P = 0.001). The diabetes-associated alleles also associated strongly with a higher plasma glucose at 30 and 120 min and serum insulin at 120 min during an oral glucose tolerance test (all P < 0.006) and the minor allele of rs1889018 with a surrogate measure of insulin sensitivity (P = 0.03). Furthermore, the diabetes-associated alleles associated with a modestly increased A1C level in the population-based Inter99 of middle-aged subjects and in the ADDITION study of high-risk individuals (P = 0.006 and P = 0.008, respectively). CONCLUSIONS: We associate sequence variation in SREBF1 with a modestly increased predisposition to type 2 diabetes. In the general population, the diabetes-associated alleles are discreetly associated with hyperglycemia presumably due to decreased insulin sensitivity. Because sterol regulatory element-binding protein-1c is a mediator of insulin action, the findings are consistent with the presence of a yet undefined subtle loss-of-function SREBF1 variant.",
author = "Niels Grarup and Stender-Petersen, {Kirstine L} and Andersson, {Ehm A} and Torben J{\o}rgensen and Knut Borch-Johnsen and Annelli Sandb{\ae}k and Torsten Lauritzen and Ole Schmitz and Torben Hansen and Oluf Pedersen",
note = "Keywords: Cohort Studies; Denmark; Diabetes Mellitus, Type 2; Genetic Variation; Glucose Tolerance Test; Humans; Insulin Resistance; Linkage Disequilibrium; Polymorphism, Single Nucleotide; Quantitative Trait Loci; Sterol Regulatory Element Binding Protein 1",
year = "2008",
doi = "10.2337/db07-1534",
language = "English",
volume = "57",
pages = "1136--42",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association",
number = "4",

}

RIS

TY - JOUR

T1 - Association of variants in the sterol regulatory element-binding factor 1 (SREBF1) gene with type 2 diabetes, glycemia, and insulin resistance: a study of 15,734 Danish subjects

AU - Grarup, Niels

AU - Stender-Petersen, Kirstine L

AU - Andersson, Ehm A

AU - Jørgensen, Torben

AU - Borch-Johnsen, Knut

AU - Sandbæk, Annelli

AU - Lauritzen, Torsten

AU - Schmitz, Ole

AU - Hansen, Torben

AU - Pedersen, Oluf

N1 - Keywords: Cohort Studies; Denmark; Diabetes Mellitus, Type 2; Genetic Variation; Glucose Tolerance Test; Humans; Insulin Resistance; Linkage Disequilibrium; Polymorphism, Single Nucleotide; Quantitative Trait Loci; Sterol Regulatory Element Binding Protein 1

PY - 2008

Y1 - 2008

N2 - OBJECTIVE: We evaluated the association of variants in the sterol regulatory element-binding factor 1 gene (SREBF1) with type 2 diabetes. Due to the previous inconclusive quantitative trait associations, we also did studies of intermediate quantitative phenotypes. RESEARCH DESIGN AND METHODS: We genotyped four variants in SREBF1 in the population-based Inter99 cohort (n = 6,070), the Danish ADDITION study (n = 8,662), and in additional type 2 diabetic patients (n = 1,002). The case-control studies involved 2,980 type 2 diabetic patients and 4,522 glucose-tolerant subjects. RESULTS: The minor alleles of rs2297508, rs11868035, and rs1889018 (linkage disequilibrium R(2) = 0.6-0.8) associated with a modestly increased risk of type 2 diabetes (rs2297508: OR 1.17 [95% CI 1.05-1.30], P = 0.003), which was confirmed in meta-analyses of all published studies (rs2297508 G-allele: 1.08 [1.03-1.14] per allele, P = 0.001). The diabetes-associated alleles also associated strongly with a higher plasma glucose at 30 and 120 min and serum insulin at 120 min during an oral glucose tolerance test (all P < 0.006) and the minor allele of rs1889018 with a surrogate measure of insulin sensitivity (P = 0.03). Furthermore, the diabetes-associated alleles associated with a modestly increased A1C level in the population-based Inter99 of middle-aged subjects and in the ADDITION study of high-risk individuals (P = 0.006 and P = 0.008, respectively). CONCLUSIONS: We associate sequence variation in SREBF1 with a modestly increased predisposition to type 2 diabetes. In the general population, the diabetes-associated alleles are discreetly associated with hyperglycemia presumably due to decreased insulin sensitivity. Because sterol regulatory element-binding protein-1c is a mediator of insulin action, the findings are consistent with the presence of a yet undefined subtle loss-of-function SREBF1 variant.

AB - OBJECTIVE: We evaluated the association of variants in the sterol regulatory element-binding factor 1 gene (SREBF1) with type 2 diabetes. Due to the previous inconclusive quantitative trait associations, we also did studies of intermediate quantitative phenotypes. RESEARCH DESIGN AND METHODS: We genotyped four variants in SREBF1 in the population-based Inter99 cohort (n = 6,070), the Danish ADDITION study (n = 8,662), and in additional type 2 diabetic patients (n = 1,002). The case-control studies involved 2,980 type 2 diabetic patients and 4,522 glucose-tolerant subjects. RESULTS: The minor alleles of rs2297508, rs11868035, and rs1889018 (linkage disequilibrium R(2) = 0.6-0.8) associated with a modestly increased risk of type 2 diabetes (rs2297508: OR 1.17 [95% CI 1.05-1.30], P = 0.003), which was confirmed in meta-analyses of all published studies (rs2297508 G-allele: 1.08 [1.03-1.14] per allele, P = 0.001). The diabetes-associated alleles also associated strongly with a higher plasma glucose at 30 and 120 min and serum insulin at 120 min during an oral glucose tolerance test (all P < 0.006) and the minor allele of rs1889018 with a surrogate measure of insulin sensitivity (P = 0.03). Furthermore, the diabetes-associated alleles associated with a modestly increased A1C level in the population-based Inter99 of middle-aged subjects and in the ADDITION study of high-risk individuals (P = 0.006 and P = 0.008, respectively). CONCLUSIONS: We associate sequence variation in SREBF1 with a modestly increased predisposition to type 2 diabetes. In the general population, the diabetes-associated alleles are discreetly associated with hyperglycemia presumably due to decreased insulin sensitivity. Because sterol regulatory element-binding protein-1c is a mediator of insulin action, the findings are consistent with the presence of a yet undefined subtle loss-of-function SREBF1 variant.

U2 - 10.2337/db07-1534

DO - 10.2337/db07-1534

M3 - Journal article

C2 - 18192539

VL - 57

SP - 1136

EP - 1142

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 4

ER -

ID: 10001223